Tipsheet
What matters at India’s listed companies
Medical Equipment · Micro cap

Raaj Medisafe CFO quits after Fabrizo deal, raises oversight questions

The resignation of CFO Kanije Fatema Dadani Patel comes just after a transformational acquisition, leaving a nano-cap with thin management depth in a critical moment.

1 earlier story on Raaj Medisafe India Ltd.
Mkt cap₹121 cr
P/E66.70×
ROE22.55%
Debt / eq.1.28
₹119 cr Market cap of nano-cap now facing CFO vacuum

What's new

  • CFO Kanije Fatema Dadani Patel resigned citing professional and personal reasons.
  • Resignation effective July 14, 2026; board accepted and sought smooth transition.
  • Departure follows Raaj Medisafe's transformational acquisition of Fabrizo Industries plant and machinery.

Why this matters

For a nano-cap with a market cap of just ₹119 cr and trailing PAT down 192.7%, the CFO's exit shortly after a major acquisition creates a vacuum in financial oversight. With limited management depth, investor trust in post-deal financial discipline is at stake.

What we're watching

  • Timeline for appointing a new CFO and transition details.
  • Q1 FY27 results for any signs of control lapses or strategic drift.
  • Any additional disclosures on the Fabrizo integration progress.

The full read

Raaj Medisafe India, a nano-cap with a market cap of approximately ₹119 crores, just lost its CFO. Kanije Fatema Dadani Patel resigned effective July 14, citing new opportunities and personal reasons. Bad timing. The departure lands right after the company announced a transformational acquisition—plant and machinery from Fabrizo Industries. For a firm with ₹25 crores in quarterly sales and a trailing profit decline of 192.7%, management depth is thin. Losing the top financial officer at such a moment raises questions about oversight of the deal and financial controls. The board asked Patel to ensure a smooth transition, but it hasn't named a successor. The next quarterly report will be the first test of whether operations remain on track without a CFO.

Questions answered

Why did the CFO of Raaj Medisafe resign?
Kanije Fatema Dadani Patel resigned to pursue new professional opportunities and for personal reasons. The company described the departure as amicable.
What is Raaj Medisafe's market cap and financial health?
Raaj Medisafe is a nano-cap with a market cap of approximately ₹119 crore. It reported a net loss of ₹3 crore on sales of ₹25 crore in the March 2026 quarter, with trailing PAT down 192.7%.
What was the recent acquisition by Raaj Medisafe?
The company acquired plant and machinery from Fabrizo Industries, described as a transformational deal for the packaging firm. The CFO's resignation came shortly after this announcement.
What risks does the CFO resignation create?
In a nano-cap with a small management team, losing the CFO creates uncertainty around financial controls, oversight of the recent acquisition, and strategic continuity. The timing raises concerns about stewardship of the transformational deal.
How will Raaj Medisafe fill the CFO position?
The board has accepted the resignation and requested a smooth transition. The company has not yet announced a replacement or a timeline for finding a new CFO.
Mentioned: Kanije Fatema Dadani Patel · Fabrizo Industries · ₹119 cr
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Raaj Medisafe India Ltd.

Pharmaceuticals
₹119 cr
P/E 65.88×

Latest quarter · Mar 2026

Sales₹25 cr
Net profit−₹3 cr
Op. margin+10.8%
EPS−₹1.96

Strength & growth

Debt / equity1.28×
Current ratio1.06×
Sales CAGR+72.7%
  1. 10 Jul 2026 · 5:35 PM IST Raaj Medisafe CFO quits after Fabrizo deal, raises oversight questions
  2. 42d ago Raaj Medisafe posts FY26 results, addresses routine board items